Pneumococcal vaccine offers protection to adults infected with HIV in Africa in the clinical trials of a vaccine trial cons a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in adults infected with HIV in Africa. The tests, conducted in Malawi, studied the effectiveness of a vaccine against infection with Streptococcus pneumoniae bacteria.
Trial Offer